Choose Your Language
Home  /  News


Join BGI at the Cell Free Circulating DNA Prague Spring Symposium 2016

--- 22 Mar 2016

Cell Free Circulating DNA Prague Spring Symposium 2016 The Centre of Medical Genetics and Reproductive Medicine (GENNET) and BGI are pleased to invite you to the Cell Free Circulating DNA Prague Spring Symposium, 2016. The symposium will consist of two half-day meetings on the afternoon of Friday, April 29 and the morning of Saturday, April 30. Friday’s session will be followed…

New Study Shows NIFTY® Outperforms Other NIPTs

--- 13 Apr 2015

On April 1st, 2015 – Researchers from the Baylor College of Medicine, the Chinese University of Hong Kong and the University of Hong Kong have published a study titled Accurate Description of DNA-Based Noninvasive Prenatal Screening in The New England Journal of Medicine. The study found that BGI’s NIFTY® test performed better than all other NIPT tests examined. In the study, researchers evaluated the performance of…

BGI Study Confirms Accuracy Of Its Non-Invasive Prenatal Test, NIFTY®, In Nearly 147,000 Pregnancies

--- 28 Jan 2015

January 28th – BGI has published a study tracking the clinical performance of its whole genome sequencing-based non-invasive prenatal test (the NIFTY® test) in nearly 147,000 pregnancies, the largest such study to date. The results showed high sensitivity and specificity and no significant difference between high-risk and low-risk pregnant women. The study, published today in the journal Ultrasound Obstetrics and…

New study indicates that the strategy of haplotype-based noninvasive prenatal testing for monogenic conditions has potential applications in clinical practice.

--- 9 Dec 2014

The goals of the study were to develop a noninvasive pre- natal test for autosomal recessive monogenic conditions and to prove its overall feasibility and potential for clinical integration. The accuracy levels of paternal and maternal haplotypes obtained by grandparent-assisted haplotype phasing were 99.01 and 97.36%, respectively, and the proband-assisted haplotype phasing process yielded slightly lower accuracies of 98.73 and…

Ground breaking Technology Transfer Agreement Between BGI Europe And NIM Genetics Creates Spain’s First Domestically Processed Non-Invasive Prenatal Test

--- 8 Dec 2014

December 3rd, 2014 – BGI Europe and NIM Genetics, one of Spain’s leading genetic diagnostics companies, are pleased to announce the signing of an exclusive technology transfer agreement whereby BGI Europe will transfer its science and technology in the field of non-invasive prenatal testing. This will enable NIM Genetics to start in-country sequencing services as part of the provision of…